Pronota N.V.
Records under this name other than patents Pronota N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,316,349 | Use of Aptamers in Proteomics Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,995,360 | Use of Aptamers in Proteomics Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,624,083 | Use of Aptamers in Proteomics Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,116,618 | Use of Aptamers in Proteomics Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,758,811 | Use of Aptamers in Proteomics Formerly held In force · High confidence | In force | High confidence | |
| US 9,315,804 | Method of Selecting Aptamers Formerly held In force · High confidence | In force | High confidence | |
| US 8,628,979 | MCAM as a biomarker for fluid homeostasis Formerly held Lapsed on the fee record Ended Jan 14, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 14, 2026 | USPTO record |
| US 10,114,021 | Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof Formerly held Lapsed on the fee record Ended Oct 30, 2022 · USPTO record | Lapsed on the fee record | Ended Oct 30, 2022 | USPTO record |
| US 6,908,740 | Methods and Apparatus for Gel-Free Qualitative and Quantitative Proteome Analysis, and Uses Therefore Formerly held Term ended Term ended Jul 8, 2022 · High confidence | Term ended | Term ended Jul 8, 2022 | High confidence |
| US 9,915,666 | MCAM as a biomarker for fluid homeostasis Formerly held Lapsed on the fee record Ended Mar 13, 2022 · USPTO record | Lapsed on the fee record | Ended Mar 13, 2022 | USPTO record |